• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ELI LILLY AND COMPANY HUMAPEN UNKNOWN; FOR TREATMENT PURPOSES

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ELI LILLY AND COMPANY HUMAPEN UNKNOWN; FOR TREATMENT PURPOSES Back to Search Results
Device Problem Mechanical Problem (1384)
Patient Problem Hyperglycemia (1905)
Event Date 08/31/2021
Event Type  Injury  
Manufacturer Narrative
Narrative field: new, updated, and corrected information is referenced within the update statements in describe event or problem.Please refer to update statement (s) dated (b)(6) 2021 in the describe event or problem field.No further follow-up is planned.Evaluation summary a female patient reported that her humapen (unspecified device type) was hard to use (unspecified issue).The patient experienced an aggravation of her diabetes mellitus.The device was not returned to the manufacturer for investigation (batch number unknown).Therefore, it could not be evaluated to confirm the complaint or presence of a malfunction.Malfunction unknown.All humapen devices are assessed for injection screw travel at the end of the manufacturing process, thus ensuring device functionality with high probability.There is no evidence of improper use or storage.
 
Event Description
(b)(4).This solicited case reported by a consumer via a patient support program (psp), concerned a (b)(6) female patient of an unknown origin.Medical history was not provided.Concomitant medications included insulin aspartate for diabetes mellitus.The patient received insulin lispro (rdna origin) injections (humalog 100u/ml) from cartridge via a reusable pen, humapen unknown device, at an unknown dose and unknown frequency, via subcutaneous route for the treatment of diabetes mellitus beginning on an unknown date.On an unknown date in (b)(6) 2021, while on insulin lispro treatment, she had the recurrence of diabetes mellitus ((b)(4) and batch number- unknown), and due to which she was hospitalized on an unknown date.Information regarding corrective treatment, outcome of event and status of insulin lispro was not provided.The operator of the humapen unknown device and his/her training status was not provided.The humapen unknown device model duration of use and suspect humapen unknown device duration of use were not reported.The action taken with the suspect humapen unknown device was not reported and its return status was not expected.The reporting consumer did not provide relatedness of event with both insulin lispro and humapen unknown device.Edit 22-nov-2021: upon review of the information dated 04-nov-2021, updated suspect device from humapen ergo ii to humapen unknown device.No other information added to the case.Update 24nov2021: additional information received on 23nov2021 from the global product complaint database.Entered device specific safety summary (dsss).Updated the medwatch fields/ european and (b)(6) (eu/(b)(6)) device information for (b)(4) associated with unknown lot of humapen unknown device.Corresponding fields and narrative updated accordingly.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
HUMAPEN UNKNOWN
Type of Device
FOR TREATMENT PURPOSES
Manufacturer (Section D)
ELI LILLY AND COMPANY
lilly corporate center
indianapolis IN 46285
Manufacturer (Section G)
PHILLIPS-MEDISIZE CORPORATION
415 red cedar street
medical device manufacturing
menomonie WI 54751
Manufacturer Contact
chris davis
lilly corporate center
indianapolis, IN 46285
3174334585
MDR Report Key12929937
MDR Text Key283266892
Report Number1819470-2021-00161
Device Sequence Number1
Product Code FMF
Combination Product (y/n)N
Reporter Country CodeCH
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Foreign,Study,Consumer,Company Representative
Reporter Occupation Non-Healthcare Professional
Type of Report Initial
Report Date 12/03/2021
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received12/03/2021
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Other
Was Device Available for Evaluation? No
Date Manufacturer Received11/04/2021
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? No
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Hospitalization;
Patient Age58 YR
Patient SexFemale
-
-